• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Apr 14, 2020
Product Development

April 13 Quick Takes: AZ’s Phase III of Tagrisso unblinded early; plus BeiGene’s tislelizumab and Fennec’s Pedmark

Read More
BioCentury | Jan 22, 2020
Clinical News

BeiGene gearing up for PD-1 competition with Merck, Innovent in 1L squamous NSCLC in China

Read More
BioCentury | Sep 9, 2019
Company News

BeiGene pushes back on short seller report

Read More
BioCentury | Aug 23, 2019
Company News

BeiGene's first U.S. NDA tests global development strategy

Read More
BioCentury | Mar 1, 2019
Company News

Celgene products drive BeiGene 4Q revenue gains

Read More
BioCentury | Feb 28, 2019
Financial News

Celgene products drive BeiGene 4Q revenue gains

Read More
BioCentury | Jan 18, 2019
Clinical News

BeiGene's BTK inhibitor gets U.S. breakthrough designation

Read More
BioCentury | Jan 4, 2019
Company News

BMS deal weighs on Celgene partners

Read More
BioCentury | Jan 4, 2019
Company News

BMS deal weighs on Celgene partners

Read More
BioCentury | Dec 27, 2018
Company News

China’s NMPA approves Innovent’s PD-1 mAb Tyvyt for Hodgkin lymphoma

Read More
Items per page:
1 - 10 of 55
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa